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Objectives. We sought to determine the features associated with
sustained monoform ventricular tachycardia (VT) in adult pa-
tients late after repair of tetralogy of Fallot (TOF) and to review
their management.
Background. Patients with repair of TOF are at risk for sudden
death. Risk factors for ventricular arrhythmia have been identi-
fied from patients with ventricular ectopic beats because of the low
prevalence of sustained VT.
Methods. From a retrospective chart review of patients as-
sessed between January 1990 and December 1994, 18 adult
patients with VT were identified and compared with 192 with
repaired TOF free of sustained arrhythmia.
Results. There was no significant difference in age at repair, age
at follow-up or operative history. Patients with VT had frequent
ventricular ectopic beats (6 of 9 vs. 21 of 101), low cardiac index
([mean 6 SD] 2.4 6 0.4 vs. 3.0 6 0.8) and more structural
abnormalities of the right ventricle (outflow tract aneurysms and
pulmonary or tricuspid regurgitation) than control patients.
Electrophysiologic map-guided operation was performed in 10 of
14 patients who required reoperation. VT has reoccurred in three
of these patients. Four patients did not undergo operation (three
received amiodarone; one underwent defibrillator implantation).
Two patients with VT also had severe heart failure and died.
Conclusions. Most patients with VT late after repair of TOF
have outflow tract aneurysms or pulmonary regurgitation, or
both. These patients have a greater frequency of ventricular
ectopic beats than arrhythmia-free patients after repair of TOF. A
combined approach of correcting significant structural abnormal-
ities (pulmonary valve replacement or right ventricular aneurys-
mectomy, or both) with intraoperative electrophysiologic-guided
ablation may reduce the potential risk of deterioration in ventric-
ular function and enable arrhythmia management to be opti-
mized.
(J Am Coll Cardiol 1997;30:1368–73)
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Follow-up studies, now available for .25 years after operation
(1–4), show that patients with tetralogy of Fallot (TOF) have
an excellent life expectancy. When late mortality occurs, it is
often sudden and attributed to ventricular arrhythmia (2,5–7).
Although ventricular arrhythmias are believed to be a common
mechanism of death in this population (8,9), the prevalence of
sustained ventricular tachycardia (VT) is low; therefore, risk
factors and prognosis for patients with VT have usually been
extrapolated from patients with frequent ventricular extrasys-
toles or brief, nonsustained salvos of VT (10–16).
Potential risk factors for ventricular arrhythmia that have
been identified include older age at intracardiac repair (11,16),
increased right ventricular systolic pressure (5), moderate or
severe pulmonary regurgitation (13), ventricular dysfunction
(15) and increased cardiopulmonary bypass time (12). Optimal
management of the patient with sustained VT has yet to be
determined.
A group of 18 patients with previous repair of TOF and
documented sustained monoform VT were reviewed to deter-
mine whether risk factors associated with this arrhythmia could
be identified and to report the long-term results of manage-
ment of these patients.
Methods
Patients. Patients with VT were identified by a retrospec-
tive chart review performed in all patients with repair of TOF
assessed at the Toronto Congenital Cardiac Centre for Adults
(TCCCA) between January 1990 and December 1994. (This
center follows up patients with congenital heart disease who
are .18 years old; their demographic and clinical data are
prospectively collected in a computerized database.) Patients
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presented with either 1) sustained symptomatic VT docu-
mented by a 12 lead-electrocardiogram (ECG), requiring
either medical therapy or electrical cardioversion to terminate
the arrhythmia, or 2) palpitations usually associated with
syncope or near syncope. These patients were subsequently
found to have sustained monoform VT at electrophysiologic
testing. Sustained VT is defined as VT .30 s in duration. A
control, arrhythmia-free group (n 5 192) was derived from the
236 patients with no history of sustained VT who were
followed up at the TCCCA between January 1990 and Decem-
ber 1994. Forty-four patients were excluded because of treat-
ment for atrial arrhythmias (n 5 17), ventricular extrasystole
(n 5 11) or a remote and poorly documented tachycardia of
uncertain etiology (n 5 16).
Surgical history, current therapy and electrophysiologic and
hemodynamic data were obtained from review of health
records. Angiographic data was interpreted by two observers
(D.H., P.M.) who had no knowledge of the patients’ clinical
status.
Electrophysiology. Standard 24-h ambulatory ECG moni-
toring is obtained approximately every 3 years for patients
followed up at our center as part of a prospective follow-up
protocol using either Cardiodata PR3 or Oxford MR4 monitor
systems. The tapes were analyzed using the Cardiodata Mark 4
system, Oxford Excel or Marquette Electronics SXP Analysis
System. Underlying rhythm, frequency of atrial and ventricular
extrasystoles, presence of ventricular couplets and duration of
nonsustained VT (.3 beats) were determined.
In those patients who underwent electrophysiologic study
(17 of 18), induction of VT was performed using a standard
protocol of pacing from the right ventricular apex at a cycle
length of 600 and 400 ms, followed by three extrasystoles. If
unsuccessful, this protocol was repeated from a midseptal site,
and burst pacing to a maximum of 250 ms was also attempted.
The intraoperative electrophysiologic mapping procedure
has been described in detail elsewhere (17,18). At the time of
operation, a customized right ventricular balloon electrode
array for recording endocardial activation was introduced
through the right atrium into the body of the right ventricle
and right ventricular outflow tract, with the patient on normo-
thermic cardiopulmonary bypass. A sock was then positioned
over the surface of the heart for epicardial recording. This
enabled the simultaneous recording of endocardial and epicar-
dial activation from 224 sites using a previously described
multiplexed recording system (18). Programmed stimulation
using a similar protocol to that outlined was used intraopera-
tively to initiate VT.
Hemodynamic measurements. Sixteen of the 18 patients
with VT underwent right and left heart catheterization as part
of their arrhythmia assessment. Postrepair measurement of
pulmonary artery pressures, right ventricular outflow tract
gradient and cardiac output were available for comparison
with a subgroup of the control patients who had previously
consented to postrepair evaluation. From this group an age-
matched hemodynamic comparison group was formed: Each
patient with VT was matched with an “arrhythmia-free” pa-
tient for both age at intracardiac repair (within 1 year) and age
at follow-up cardiac catheterization.
Angiographic measurements. In patients presenting with
VT, cardiac angiography was obtained to assess pulmonary and
tricuspid valve competence and right ventricular morphology
and function. In describing right ventricular morphology, we
defined an aneurysm as a discrete area of the outflow tract with
diastolic deformity and systolic filling; diffuse dilation of the
outflow tract was not included in the definition. Because
angiography was not performed routinely in patients without
arrhythmias, a comparison group was derived from a random
sample of patients undergoing angiography for hemodynamic
indications (congestive heart failure, before pulmonary valve
replacement).
Data analysis. Results are presented as mean value 6 SD,
and 95% confidence intervals are provided where appropriate.
Patients with VT and control patients without VT were
compared using a two-tailed Student t test. Hemodynamic data
were analyzed using the Wilcoxon rank sum test. Categoric
data were examined using chi-square or Fisher exact tests,
where appropriate.
Results
Patients. A total of 18 patients with VT (14 male, 4 female;
20 to 62 years old) were identified and compared with 192
“arrhythmia-free” patients (108 male, 84 female; 18 to 68 years
old). There were no significant differences in mean age at
intracardiac repair (11.2 6 11.8 years, 95% confidence interval
[CI] 5.3 to 17.1 vs. 11.5 6 10.5 years, 95% CI 10.0 to 13.0,
respectively) or age at last follow-up visit (33.2 6 10.9 years,
95% CI 27.8 to 38.6 vs. 30.7 6 10.4 years, 95% CI 29.2 to 32.2
years, respectively). Palliative shunt operations had been per-
formed in 11 of 18 patients with VT (Blalock-Taussig in 9,
Waterston in 2; 95% CI 0.36 to 0.83) and in 118 of 192 control
patients (Blalock-Taussig in 105, Waterston, Potts in 5; 95% CI
0.55 to 0.68).
Electrophysiologic findings. Monoform VT was docu-
mented electrocardiographically in 15 of the 18 patients before
referral for electrophysiologic study. The primary symptom at
presentation was resuscitated cardiac arrest (n 5 1), syncope
(n 5 3), presyncope (n 5 10) and palpitation alone (n 5 1).
The remaining three patients had experienced recurrent pal-
pitations, with frequent multiform ventricular extrasystoles on
24-h ambulatory ECG monitoring, and were subsequently
Abbreviations and Acronyms
CI 5 confidence interval
ECG 5 electrocardiogram, electrocardiographic
ICD 5 implantable cardioverter-defibrillator
VSD 5 ventricular septal defect
VT 5 ventricular tachycardia
TCCCA 5 Toronto Congenital Cardiac Centre for Adults
TOF 5 tetralogy of Fallot
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found to have inducible sustained VT at electrophysiologic
study. For the complete group of 18 patients, the mean rate of
VT was 230 beats/min (range 188 to 300), with a left bundle
branch block configuration in 75% of patients.
Electrophysiologic study was obtained in 17 of the 18
patients: The remaining patient with documented VT pre-
sented with severe mitral regurgitation subsequent to bacterial
endocarditis and was referred for urgent operation. Using the
protocol described, 14 of 17 patients who had electrophysi-
ologic study had inducible VT at electrophysiologic testing.
Twenty-four hour ambulatory ECGs obtained without an-
tiarrhythmic therapy and before presentation with VT were
available for 9 of the 18 patients. Frequent ventricular extra-
systoles (defined as .30/min in any hour or nonsustained VT
[.3 beats] or both) were present in six of these patients (67%,
95% CI 30% to 93%). In comparison, 21 of 101 arrhythmia-
free patients (21%, 95% CI 13% to 29%) had frequent
extrasystoles (p , 0.01).
Hemodynamic characteristics. Right heart catheterization
with an age-matched comparison group was available for 15 of
18 patients with VT (Table 1). Cardiac index was significantly
lower in the group presenting with VT. Cardiac output was
measured by the Fick technique in half the patients and by the
thermodilution technique in the remainder. It is recognized
that the latter technique may be less reliable in the presence of
pulmonary or tricuspid regurgitation. There was no difference
in either right ventricular or pulmonary artery systolic or
diastolic pressures. There was a nonsignificant trend toward
lower pulmonary artery diastolic pressure and to greater
pulmonary artery pulse pressure in patients with VT.
Angiography. Angiograms were available for review in 14
patients with VT. Moderate or severe tricuspid regurgitation
was present in 3 patients, moderate or severe pulmonary
regurgitation in 11 and a right ventricular outflow tract aneu-
rysm in 11. At least one of these abnormalities was present in
12 (85%) of 14 patients. The comparison group included 14
patients without VT who underwent cardiac angiography for
other clinical indications (heart failure, preoperative valvular
assessment): 7 of these patients (50%) had no significant
abnormality, and none had moderate or severe tricuspid
regurgitation. Moderate or severe pulmonary regurgitation
was present in five patients and right ventricular outflow tract
aneurysm in six.
Management. Medical management of VT involved the
use of two or more different antiarrhythmic medications in 16
of the 18 patients. The medications used included amiodarone
(13 patients), mexiletine (9 patients), quinidine (7 patients),
sotalol (7 patients), procainamide (4 patients) and propa-
fenone (4 patients).
Operation subsequent to the onset of VT was performed in
14 patients. Pulmonary valve repair (n 5 1) or replacement
(n 5 10) was undertaken in 11 of the patients. In addition, 9 of
these 11 patients had right ventricular outflow tract reconstruc-
tion with aneurysmectomy. VT could be induced in eight
patients undergoing pulmonary valve reoperation (valve re-
placement in seven, valve repair in one), all of whom under-
went cryoablation. The infundibular septum at its juncture with
the ventricular septal defect (VSD) patch, parietal band or
right ventricular free wall was the predominant region identi-
fied by intraoperative electrophysiologic mapping as the site of
origin of VT.
Two patients underwent cryoablation without pulmonary
valve surgery: resection of an outflow tract aneurysm with
intraoperative cryoablation in one, cryoablation alone to a
reentry circuit mapped to the site of a surgical pledget in the
other.
One patient had mitral valve replacement subsequent to
bacterial endocarditis. No electrophysiologic assessment was
obtained in this patient intraoperatively, and this patient
continued to experience problems with left ventricular dys-
function and prosthetic valve failure and died of heart failure
9 months after operation (8 years after presentation with the
first episode of VT).
Four patients did not undergo operation subsequent to the
onset of VT. One patient diagnosed at our center but subse-
quently managed elsewhere underwent placement of an im-
Table 1. Hemodynamic Measurements
Patients With VT
(mean 6 SD)
Control Group
(mean 6 SD) p Value Power
Age at repair (yr) 9.3 6 7.0 9.2 6 7.0 1.0
Age at cath (yr) 27.5 6 8.7 27.6 6 8.4 1.0
Mean RAP (mm Hg) 7.9 6 3.3 6.5 6 3.4 0.26 0.37
RVP systolic (mm Hg) 47.9 6 20.8 47.8 6 17.4 0.98 0.03
RVP diastolic (mm Hg) 8.4 6 2.7 7.8 6 4.5 0.62 0.10
PAP systolic (mm Hg) 32.0 6 12.6 32.9 6 20.7 0.49 0.10
PAP diastolic (mm Hg) 6.5 6 3.3 8.6 6 3.3 0.13 0.69
PAP mean (mm Hg) 14.9 6 2.8 18.8 6 13.8 0.62 0.33
PAPP (mm Hg) 25.5 6 12.1 19.9 6 12.1 0.15 0.43
RVOT gradient (mm Hg) 14.7 6 10.4 20.1 6 15.2 0.45 0.36
Cardiac index (liters/min per m2)* 2.4 6 0.4 3.0 6 0.8 0.03
*Only 11 control subjects and 10 patients (Pts) with ventricular tachycardia (VT). cath 5 catheterization; PAP 5
pulmonary artery pressure; PAPP 5 pulmonary artery pulse pressure; Power 5 power to detect differences at p 5 0.05;
RAP 5 right atrial pressure; RVOT 5 right ventricular outflow tract; RVP 5 right ventricular pressure.
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plantable cardioverter-defibrillator (ICD) as primary manage-
ment without surgical assessment. The other three patients
were treated with amiodarone: One patient had a large
residual VSD, moderate right ventricular dysfunction, moder-
ate pulmonary regurgitation and severe tricuspid regurgitation
and was treated for heart failure but died while awaiting
surgical closure of his VSD; a second patient was awaiting
operation at the time of this writing; a third patient did not
have a structural indication for operation and has remained
arrhythmia free 1 year after commencing amiodarone therapy.
Follow-up. As previously described, two patients died late
after onset of VT. Both patients were in New York Heart
Association functional class IV before their deaths. One of
these patients died suddenly at home while receiving aggres-
sive diuresis for exacerbation of heart failure. Sudden death
occurred in 2 of 192 patients in the control group: 1 had known
coronary artery disease and moderate left ventricular dysfunc-
tion, and the second patient had biventricular dilation present
at autopsy.
Operation was an integral part of the management for 14 of
the 18 patients with VT. Follow-up data are available for the
surgical patients at 4.0 6 3.5 years since operation. All but one
surgical patient had assessment for cryoablation intraopera-
tively (Fig. 1). In three of these patients, VT could not be
induced at operation. One of these three patients has had a
clinical recurrence of monoform VT and is now receiving
amiodarone therapy. Two patients have remained free of
recurrence: One has stopped therapy, and VT is no longer
inducible at electrophysiologic study; the other is maintained
with the same therapy as that received preoperatively.
Cryoablation was performed in the 10 patients with VT
inducible intraoperatively. Eight patients who underwent
cryoablation have been free of sustained monoform VT; two
have had recurrence (one now has an ICD; the other received
amiodarone). Two patients had brief, nonsustained asymptom-
atic salvos of VT on routine monitoring: Mexiletine therapy
was commenced in one and amiodarone in the other, and both
have since remained arrhythmia free.
Discussion
Monoform VT was identified in 18 of 254 patients late after
repair of TOF. Factors found in the present study to be
associated with VT include frequent ventricular extrasystoles
and low cardiac index. Important abnormalities of the right
ventricle (nonsignificant trends for each of moderate to severe
pulmonary regurgitation, right ventricular outflow tract aneu-
rysms and moderate to severe tricuspid regurgitation) were
also more common in patients with VT.
Ventricular ectopic beats. Although ambulatory monitor-
ing data were not available for all patients, the group with VT
nonetheless exhibited a significantly higher frequency of ven-
tricular extrasystoles. The latter have previously been identi-
fied as a significant risk factor for sudden death in TOF (6,9)
and correlate with ability to induce VT at electrophysiologic
study (16). Risk factors for ventricular ectopic activity (Lown
grade $2) after repair of TOF have been reported to include
older age at repair (11,16), moderate or severe pulmonary
regurgitation (13), increased right ventricular systolic pressure
(5), ventricular dysfunction (15) and longer cardiopulmonary
bypass time (12).
Influence of age. Compared with the arrhythmia-free co-
hort, patients with VT in our study were of comparable age at
intracardiac repair and at follow-up and had had a similar
surgical history before intracardiac repair. However, many
underwent operation at an older age than that considered
current practice, with the majority of patients now undergoing
repair in infancy. A significant effect of increasing age at time
of definitive repair on ventricular arrhythmias has been previ-
ously reported (11,16). Older average age at time of initial
repair was also observed in our control group and may reflect
the nature of the population followed up at the TCCCA:
Figure 1. Schematic detailing arrhythmia out-
come for the 14 patients undergoing operation.
EP 5 electrophysiologic study; ICD 5 implant-
able cardioverter-defibrillator; MVR 5 mitral
valve replacement; NSVT 5 nonsustained ven-
tricular tachycardia; SBE 5 subacute bacterial
endocarditis; VT 5 ventricular tachycardia.
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patients are $18 years old at initial referral, and many
underwent operation in an earlier surgical era, when corrective
operation was unusual at ,5 years of age.
Pulmonary insufficiency. Twelve (86%) of 14 patients with
VT who underwent angiography had important abnormalities
of the right heart: moderate or severe tricuspid or pulmonary
regurgitation or right ventricular outflow tract aneurysms. Our
observation that valvular abnormalities are more often present
in patients with VT is consistent with the previous observations
of Zahka et al. (13). In their prospective study of valvular
function in 59 patients after repair of TOF, the presence of at
least moderate pulmonary regurgitation correlated with the
presence of ventricular couplets or nonsustained VT on am-
bulatory monitoring. Similarly, the presence of these arrhyth-
mias correlated with any severity of tricuspid regurgitation. As
in our study, Zahka et al. (13) found no relation between
ventricular arrhythmias and right ventricular outflow tract
gradient. The mechanism by which pulmonary regurgitation
might facilitate the initiation of VT is not certain. Zahka et al.
observed a correlation between the severity of pulmonary
regurgitation and diastolic right ventricular area: Right ven-
tricular enlargement with myocardial stretch would in turn
provide an appropriate substrate for ventricular arrhythmias.
The importance of right ventricular volume overload as a
potential risk factor for VT has recently been addressed by
Gatzoulis et al. (19), who found that patients with restrictive
right ventricular physiology by Doppler assessment after repair
were protected from the effects of pulmonary regurgitation
and late ventricular arrhythmias, whereas patients with VT
exhibited nonrestrictive physiology, right ventricular enlarge-
ment and QRS prolongation.
Outflow tract aneurysms. The coexistence of significant
pulmonary regurgitation with aneurysmal dilation of the right
ventricular outflow tract may provide a second explanation for
the prevalence of pulmonary regurgitation in patients with VT.
Of the 14 patients with ventricular arrhythmias who underwent
angiography, 79% had outflow tract aneurysms. Our compar-
ison group with 43% prevalence of aneurysm had undergone
angiography for clinical indications and as such are unlikely to
represent a normal population of patients after repair of TOF.
Earlier reports of aneurysm formation after repair of TOF
have suggested an incidence of 4% to 6% during long-term
follow-up (20,21).
Aneurysmal dilation of the right ventricular outflow tract
appears to provide a suitable substrate for ventricular arrhyth-
mias in these patients. Histopathologic studies (22–23) in this
population have confirmed the presence of isolated bundles of
myocardial cells, surrounded by extensive fibrosis in the margin
of the right ventricular outflow tract patch/right ventricular
free wall junction. These findings are not unlike the changes
observed in the border zone of the aneurysm in ischemic heart
disease, a zone widely accepted as providing the substrate for
VT in ischemic heart disease (24,25). We and others (26,27)
previously confirmed the mechanism of VT in TOF to be due
to reentry. Premature stimuli during electrophysiologic map-
ping can evoke transient block and critical delays in activation,
facilitating the initiation of the reentrant circuit. These abnor-
malities of conduction are presumably the functional manifes-
tations of the pathologic findings previously described. The
more recent study by Misaki et al. (23) attempted to correlate
similar abnormalities of conduction in patients with VT after
repair of TOF with the histologic findings described above.
Although some of the histologic changes described may rep-
resent the natural history of this congenital abnormality, there
is considerable evidence that most of these changes are the
consequence of the initial surgical repair. This finding is
supported by observations of Dietl et al. (28), who compared
the outcome of the transatrial versus the transventricular
approach for initial repair of TOF. Although the comparison
was of a consecutive rather than concurrent series of patients,
the results suggested a significant reduction in ventricular
arrhythmias using the transatrial approach with preservation of
pulmonary valve and right ventricular function. Dietl et al. (28)
concluded that a right ventriculotomy scar significantly in-
creased the risk of ventricular arrhythmias.
Follow up. The majority of our patients (14 of 18) under-
went operation subsequent to the development of VT; in most
instances for severe pulmonary regurgitation and right ventric-
ular outflow tract aneurysm resection. Suitability for intraop-
erative electrophysiologic mapping was assessed in all but one
of the surgical patients, and cryoablation was performed in 10.
With postsurgical follow-up of 4.0 6 3.5 years, there has been
arrhythmia free survival in 10 of the surgical group.
Limitations of the study. This was a retrospective study in
a patient cohort from a tertiary referral center. As such, we
made no attempt to comment on the incidence of sustained VT
in the adult population with repair of TOF. However, the
majority of patients are followed up serially through the
TCCFA, which serves as the continuity center for the Hospital
for Sick Children, where most of the definitive repair of TOF
for our region is performed.
Although the ambulatory ECG data are consistent with
the observation of others (9,10,16), the hemodynamic/
angiographic comparison group may not be reflective of the
average patient with repair of TOF during follow-up. The
latter is biased toward the patient being investigated for
symptoms—usually congestive heart failure or preoperative
valve assessment.
The management described was individualized. This was a
retrospective study and not part of a randomized, controlled
trial. In addition, because of the small sample size, the study
may not have sufficient power to detect clinically relevant
differences.
Conclusions and clinical applications. Two patients have
died in the group with VT. Both patients had severe symptom-
atic heart failure. We believe that correction of the underlying
structural problems may be as important in the long-term
outcome of these patients as management of their potentially
life-threatening arrhythmias. Indeed, it is possible that surgical
repair alone may have an important moderating effect on the
ventricular arrhythmias. Although treatment of the arrhythmia
may be possible through the use of antiarrhythmic medication
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or an ICD, such an approach may not be ideal in the long term
for all patients. Eighty percent of patients undergoing intraop-
erative map-guided operation in the present study have re-
mained free of sustained VT during long-term follow-up.
Patients with repair of TOF who present with sustained VT
should be assessed for surgical intervention. A combined
approach of correcting significant structural abnormalities in
conjunction with intraoperative electrophysiologically guided
ablation enables arrhythmia management to be optimized and
may reduce the potential risk of deterioration in ventricular
function.
We gratefully acknowledge Cyrus Salimi for assistance with data acquisition.
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